[BEAT] BioTelemetry, Inc.

Overview

Type of security: Stock

Sector: Health Care

Industry: Medical Specialities

Market Capitalization:

Exchange: NASDAQ

The data is delayed by 15 minutes.

 

Price: 23 Change: -0.35 (-1.5%)
Ext. hours: Change: 0 (0%)

chart BEAT

Refresh chart

Strongest Trends Summary For BEAT

BEAT is in the medium-term down -50% below S&P in 1 year. In the long-term up 1149% in 12 years.

Horizon: 3 hours | 2 days | 5 days | 10 days | 1 month | 6 months | 1 year | 2 years | 5 years | max

Chart type: absolute | relative to S&P

Publish chart

 

Description: BioTelemetry, Inc. provides cardiac monitoring, cardiac monitoring device manufacturing, and cardiac core laboratory services. It operates in three segments: Patient Services, Product, and Research Services. The Patient Services segment focuses on the diagnosis and monitoring of cardiac arrhythmias or heart rhythm disorders. This segment offers Mobile Cardiac Outpatient Telemetry service, which incorporates a lightweight patient-worn sensor attached to electrodes that capture two-channel electrocardiography (ECG) data, measuring electrical activity of the heart, on a compact wireless handheld monitor; event monitoring services to prescribe wireless event monitors, digital loop event monitors, memory loop event monitors, and non-loop event monitors; and a Holter monitor to cardiologists and electrophysiologists. The Product segment focuses on the manufacture, engineering, and development of noninvasive cardiac monitors for healthcare companies, clinics, and hospitals worldwide. This segment offers various devi

Fundamental Ratios
Shares Outstanding EPS EPS Growth - 4 Quarters EPS Growth - Q/Q
EPS Growth - Y/Y Sales Growth - 4 Quarters 1.84% Sales Growth - Q/Q-0.5% P/E
P/E To EPS Growth P/S P/BV Price/Cash Per Share
Price/Free Cash Flow ROA-4.9% ROE-8.96% ROI
Current Ratio1.54 Quick Ratio1.43 Long Term Debt/Equity1.56 Debt Ratio0.43
Gross Margin56.14% Operating Margin-0.09% Net Profit Margin-3.32% Dividend Payout Ratio
Dividend Yield
Fundamental Data
Cash From Financing Activities Cash From Investing Activities-1.04 M Cash From Operating Activities-2.07 M Gross Profit25.22 M
Net Profit-4.61 M Operating Profit470 K Total Assets117.16 M Total Current Assets42.32 M
Total Current Liabilities27.54 M Total Debt23.11 M Total Liabilities53.11 M Total Revenue43.44 M
Technical Data
High 52 week77.59 Low 52 week41.92 Last close41.99 Last change-1.73%
RSI39.23 Average true range2.13 Beta0.77 Volume232.81 K
Simple moving average 20 days-6.41% Simple moving average 50 days-11.19% Simple moving average 200 days-28.37%
Performance Data
Performance Week-0.1% Performance Month-12.54% Performance Quart-17.05% Performance Half-43.24%
Performance Year-27.42% Performance Year-to-date-29.69% Volatility daily2.43% Volatility weekly5.43%
Volatility monthly11.12% Volatility yearly38.52% Relative Volume858.67% Average Volume405.31 K
New High New Low

News

2020-05-07 16:01:16 | BioTelemetry Inc BEAT Q1 2020 Earnings Call Transcript

2020-05-07 10:22:39 | Edited Transcript of BEAT earnings conference call or presentation 6-May-20 9:00pm GMT

2020-05-06 16:05:10 | BioTelemetry, Inc. Reports First Quarter 2020 Financial Results

2020-05-01 06:40:27 | What Is BioTelemetry's NASDAQ:BEAT P/E Ratio After Its Share Price Rocketed?

2020-04-29 13:13:00 | BioTelemetry, Inc. to Release First Quarter 2020 Earnings Results on May 6, 2020

2020-04-27 09:05:38 | BioTelemetry, Inc. to Move to Virtual-only Annual Stockholder Meeting for 2020

2020-04-22 08:44:12 | Is a Surprise Coming for BioTelemetry BEAT This Earnings Season?

2020-04-16 12:31:04 | BioTelemetry BEAT to Report Q1 Results: Wall Street Expects Earnings Growth

2020-04-16 06:15:00 | How Does BioTelemetry's NASDAQ:BEAT P/E Compare To Its Industry, After Its Big Share Price Gain?

2020-04-15 12:28:58 | Hedge Funds Are Selling BioTelemetry, Inc. BEAT

2020-04-07 10:29:41 | BioTelemetry, Inc. Names Dr. Andrei Stoica Chief Technology Officer

2020-04-03 09:00:46 | Why This Coronavirus Testing Outlet Is Among 4 Key Plays Amid Covid-19

2020-03-27 06:37:43 | How Does BioTelemetry's NASDAQ:BEAT P/E Compare To Its Industry, After The Share Price Drop?

2020-03-25 09:21:40 | BIOTELEMETRY, INC. EXPANDS MCOT™ SERVICE TO MONITOR LIFE-THREATENING QT PROLONGATION IN COVID-19 PATIENTS

2020-03-13 06:34:58 | How Does BioTelemetry's NASDAQ:BEAT P/E Compare To Its Industry, After The Share Price Drop?

2020-03-05 13:29:02 | Edited Transcript of BEAT earnings conference call or presentation 26-Feb-20 10:00pm GMT

2020-02-26 18:25:11 | BioTelemetry BEAT Q4 Earnings Meet Estimates

2020-02-26 16:05:10 | BioTelemetry, Inc. Reports Fourth Quarter 2019 Financial Results

2020-02-26 13:39:22 | Here's Why We Think BioTelemetry NASDAQ:BEAT Is Well Worth Watching

2020-02-19 12:31:05 | Earnings Preview: BioTelemetry BEAT Q4 Earnings Expected to Decline

2020-02-18 16:05:10 | BioTelemetry, Inc. to Release Fourth Quarter 2019 Earnings Results on February 26, 2020

2020-02-13 12:31:05 | Earnings Preview: BioTelemetry BEAT Q4 Earnings Expected to Decline

2020-02-04 06:18:55 | Should You Worry About BioTelemetry, Inc.'s NASDAQ:BEAT CEO Salary Level?

2020-01-12 08:18:48 | Don't Sell BioTelemetry, Inc. NASDAQ:BEAT Before You Read This

2019-12-20 13:09:54 | Is BioTelemetry, Inc.'s NASDAQ:BEAT ROE Of 11% Impressive?

2019-12-11 12:16:46 | Should You Buy BioTelemetry, Inc. BEAT?

2019-11-28 05:29:19 | Does BioTelemetry, Inc. NASDAQ:BEAT Have A Particularly Volatile Share Price?

2019-11-11 18:40:49 | Edited Transcript of BEAT earnings conference call or presentation 5-Nov-19 10:00pm GMT

2019-11-11 13:12:10 | Mario Gabelli Continues to Buy AbbVie, Axalta

2019-11-05 19:05:12 | BioTelemetry BEAT Beats Q3 Earnings and Revenue Estimates

2019-11-05 16:05:00 | BioTelemetry, Inc. Reports Third Quarter 2019 Financial Results

2019-11-02 09:19:10 | If You Had Bought BioTelemetry NASDAQ:BEAT Shares Five Years Ago You'd Have Made 414%

2019-10-29 14:54:57 | BioTelemetry, Inc. to Release Third Quarter 2019 Earnings Results on November 5, 2019

2019-10-28 09:13:33 | Were Hedge Funds Right About Dumping BioTelemetry, Inc. BEAT?

2019-10-07 08:07:37 | What Does BioTelemetry, Inc.'s NASDAQ:BEAT Share Price Indicate?

2019-09-10 14:30:38 | Is BioTelemetry, Inc.'s NASDAQ:BEAT Capital Allocation Ability Worth Your Time?

2019-09-03 16:05:00 | BioTelemetry, Inc. Named to Fortune Magazine’s 100 Fastest-Growing Companies List

2019-08-15 12:44:20 | BioTelemetry NASDAQ:BEAT Has A Pretty Healthy Balance Sheet

2019-08-05 12:07:32 | BioTelemetry, Inc. Names Manish Wadhwa, M.D., F.H.R.S. Chief Medical Officer

2019-07-31 10:16:15 | Edited Transcript of BEAT earnings conference call or presentation 30-Jul-19 9:00pm GMT

2019-07-30 22:24:32 | BioTelemetry Inc BEAT Q2 2019 Earnings Call Transcript

2019-07-30 20:05:12 | BioTelemetry BEAT Q2 Earnings and Revenues Beat Estimates

2019-07-30 16:05:00 | BioTelemetry, Inc. Reports Second Quarter 2019 Financial Results

2019-07-24 08:30:00 | BioTelemetry, Inc. Acquires Sweden-based ADEA Medical AB and Expands International Service Offering

2019-07-23 10:32:02 | Analysts Estimate BioTelemetry BEAT to Report a Decline in Earnings: What to Look Out for

2019-07-19 17:58:57 | BioTelemetry, Inc. to Release Second Quarter 2019 Earnings Results on July 30, 2019

2019-07-18 09:58:01 | BioTelemetry BEAT to Report Q2 Earnings: What's in Store?

2019-07-17 10:32:02 | Analysts Estimate BioTelemetry BEAT to Report a Decline in Earnings: What to Look Out for

2019-07-16 14:24:08 | Does BioTelemetry, Inc.'s NASDAQ:BEAT CEO Salary Compare Well With Others?

2019-06-13 07:07:20 | With A Return On Equity Of 15%, Has BioTelemetry, Inc.'s NASDAQ:BEAT Management Done Well?